HI
CRVO icon

Harbour Investments’s CervoMed CRVO Stock Holding History

Harbour Investments’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-66
Closed -$964 – 3506
2024
Q3 		$964 Hold
66
– – ﹤0.01% 3097
2024
Q2 		$1.13K Hold
66
– – ﹤0.01% 2970
2024
Q1 		$1.54K Hold
66
– – ﹤0.01% 2839
2023
Q4 		$504 Buy
+66
New +$571 ﹤0.01% 2929

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Harbour Investments's CRVO Position: Q4 2024 in Review

Harbour Investments sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 66 shares — an estimated $964 sold.

Harbour Investments first reported a position in CRVO in Q4 2023 and held it in 4 quarters. The position peaked at $1.54K in Q1 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

  • Harbour Investments reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
  • Harbour Investments sold 66 CervoMed shares in Q4 2024, an estimated $964.
  • Harbour Investments first reported a position in CervoMed in Q4 2023 and held it in 4 quarters.
  • Harbour Investments's CervoMed position peaked at $1.54K in Q1 2024.
  • 49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on Harbour Investments's 13F filing for Q4 2024, filed 10 Feb 2025.